nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSL—neck—salivary gland cancer	0.0369	0.0799	CbGeAlD
Boceprevir—CMA1—connective tissue—salivary gland cancer	0.0309	0.067	CbGeAlD
Boceprevir—CTSL—parotid gland—salivary gland cancer	0.0301	0.0651	CbGeAlD
Boceprevir—CTSL—saliva-secreting gland—salivary gland cancer	0.0288	0.0623	CbGeAlD
Boceprevir—CTSL—connective tissue—salivary gland cancer	0.0265	0.0573	CbGeAlD
Boceprevir—CTSL—epithelium—salivary gland cancer	0.0251	0.0544	CbGeAlD
Boceprevir—CTSS—neck—salivary gland cancer	0.0244	0.0528	CbGeAlD
Boceprevir—CTSV—lymphoid tissue—salivary gland cancer	0.0237	0.0513	CbGeAlD
Boceprevir—CTSK—parotid gland—salivary gland cancer	0.0227	0.049	CbGeAlD
Boceprevir—CMA1—lymphoid tissue—salivary gland cancer	0.0226	0.049	CbGeAlD
Boceprevir—CTSK—saliva-secreting gland—salivary gland cancer	0.0217	0.047	CbGeAlD
Boceprevir—CTSK—connective tissue—salivary gland cancer	0.0199	0.0432	CbGeAlD
Boceprevir—CTSS—parotid gland—salivary gland cancer	0.0199	0.043	CbGeAlD
Boceprevir—CTSL—lymphoid tissue—salivary gland cancer	0.0194	0.0419	CbGeAlD
Boceprevir—CTSS—saliva-secreting gland—salivary gland cancer	0.019	0.0412	CbGeAlD
Boceprevir—CTSS—connective tissue—salivary gland cancer	0.0175	0.0378	CbGeAlD
Boceprevir—CTSK—lymphoid tissue—salivary gland cancer	0.0146	0.0316	CbGeAlD
Boceprevir—CTSS—lymphoid tissue—salivary gland cancer	0.0128	0.0277	CbGeAlD
Boceprevir—CMA1—lymph node—salivary gland cancer	0.0128	0.0276	CbGeAlD
Boceprevir—CTSL—lymph node—salivary gland cancer	0.0109	0.0236	CbGeAlD
Boceprevir—CTSK—lymph node—salivary gland cancer	0.00823	0.0178	CbGeAlD
Boceprevir—CTSS—lymph node—salivary gland cancer	0.00721	0.0156	CbGeAlD
Boceprevir—CTSL—Extracellular matrix organization—VCAN—salivary gland cancer	0.00455	0.00847	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—VCAN—salivary gland cancer	0.00455	0.00847	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FOXO3—salivary gland cancer	0.00451	0.00838	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—ITGB4—salivary gland cancer	0.00443	0.00824	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ISL1—salivary gland cancer	0.00438	0.00814	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—VCAN—salivary gland cancer	0.00423	0.00787	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—CDH1—salivary gland cancer	0.00422	0.00784	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—CDH1—salivary gland cancer	0.00422	0.00784	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—IGFBP2—salivary gland cancer	0.00396	0.00736	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—MAP2K2—salivary gland cancer	0.00396	0.00736	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—MAP2K2—salivary gland cancer	0.00396	0.00736	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—CDH1—salivary gland cancer	0.00392	0.00729	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—VCAN—salivary gland cancer	0.00377	0.00701	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—MAP2K2—salivary gland cancer	0.00368	0.00684	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—FBXW7—salivary gland cancer	0.00361	0.00671	CbGpPWpGaD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—FBXW7—salivary gland cancer	0.00361	0.00671	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—GAS6—salivary gland cancer	0.00353	0.00656	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—CDH1—salivary gland cancer	0.00349	0.00649	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—MAP2K2—salivary gland cancer	0.00328	0.0061	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—VCAN—salivary gland cancer	0.00311	0.00578	CbGpPWpGaD
Boceprevir—CYP3A5—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.0031	0.00576	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—DTX4—salivary gland cancer	0.0031	0.00576	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—DTX4—salivary gland cancer	0.0031	0.00576	CbGpPWpGaD
Boceprevir—ABCB1—epithelium—salivary gland cancer	0.00293	0.00633	CbGeAlD
Boceprevir—CTSS—Degradation of the extracellular matrix—CDH1—salivary gland cancer	0.00288	0.00535	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CYLD—salivary gland cancer	0.0028	0.00521	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CYLD—salivary gland cancer	0.0028	0.00521	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ST3GAL4—salivary gland cancer	0.00277	0.00515	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—MAP2K2—salivary gland cancer	0.0027	0.00502	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PRKDC—salivary gland cancer	0.00269	0.00499	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PRKDC—salivary gland cancer	0.00269	0.00499	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—DTX4—salivary gland cancer	0.00257	0.00477	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGF16—salivary gland cancer	0.00256	0.00476	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGF16—salivary gland cancer	0.00256	0.00476	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—FBXW7—salivary gland cancer	0.00246	0.00458	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGF16—salivary gland cancer	0.00246	0.00457	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGF16—salivary gland cancer	0.00246	0.00457	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00236	0.00439	CbGpPWpGaD
Boceprevir—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00234	0.00435	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CYLD—salivary gland cancer	0.00232	0.00431	CbGpPWpGaD
Boceprevir—ABCB1—lymphoid tissue—salivary gland cancer	0.00225	0.00488	CbGeAlD
Boceprevir—CTSK—Innate Immune System—PRKDC—salivary gland cancer	0.00222	0.00414	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FGF16—salivary gland cancer	0.00212	0.00395	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—DTX4—salivary gland cancer	0.00211	0.00393	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FGF16—salivary gland cancer	0.00204	0.00379	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—PTEN—salivary gland cancer	0.00195	0.00363	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CYLD—salivary gland cancer	0.00191	0.00355	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGFR4—salivary gland cancer	0.00189	0.00352	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGFR4—salivary gland cancer	0.00189	0.00352	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PRKDC—salivary gland cancer	0.00183	0.00341	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGFR4—salivary gland cancer	0.00182	0.00338	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGFR4—salivary gland cancer	0.00182	0.00338	CbGpPWpGaD
Boceprevir—CTSV—Immune System—DTX4—salivary gland cancer	0.0018	0.00335	CbGpPWpGaD
Boceprevir—CTSL—Immune System—DTX4—salivary gland cancer	0.0018	0.00335	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FBXW7—salivary gland cancer	0.00179	0.00332	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FBXW7—salivary gland cancer	0.00179	0.00332	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—CDH1—salivary gland cancer	0.00177	0.00328	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—CDH1—salivary gland cancer	0.00177	0.00328	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGF16—salivary gland cancer	0.00175	0.00325	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGF16—salivary gland cancer	0.00168	0.00312	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—CDH1—salivary gland cancer	0.00164	0.00305	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CYLD—salivary gland cancer	0.00163	0.00303	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CYLD—salivary gland cancer	0.00163	0.00303	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—WNT5B—salivary gland cancer	0.00158	0.00293	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FOXO3—salivary gland cancer	0.00157	0.00292	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FOXO3—salivary gland cancer	0.00157	0.00292	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FGFR4—salivary gland cancer	0.00157	0.00291	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PRKDC—salivary gland cancer	0.00156	0.00291	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PRKDC—salivary gland cancer	0.00156	0.00291	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL17RD—salivary gland cancer	0.00152	0.00283	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—FBXW7—salivary gland cancer	0.00151	0.00281	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FOXO3—salivary gland cancer	0.00151	0.0028	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FOXO3—salivary gland cancer	0.00151	0.0028	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FGFR4—salivary gland cancer	0.00151	0.0028	CbGpPWpGaD
Boceprevir—CTSK—Immune System—DTX4—salivary gland cancer	0.00149	0.00278	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGF16—salivary gland cancer	0.00149	0.00277	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGF16—salivary gland cancer	0.00149	0.00277	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FBXW7—salivary gland cancer	0.00148	0.00275	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—CDH1—salivary gland cancer	0.00146	0.00272	CbGpPWpGaD
Boceprevir—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00144	0.00268	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NUP62—salivary gland cancer	0.00143	0.00266	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NUP62—salivary gland cancer	0.00143	0.00266	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAML3—salivary gland cancer	0.00139	0.00259	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.00138	0.00256	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CYLD—salivary gland cancer	0.00135	0.00251	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FOXO3—salivary gland cancer	0.0013	0.00242	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PRKDC—salivary gland cancer	0.0013	0.00241	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGFR4—salivary gland cancer	0.00129	0.0024	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—MAP2K2—salivary gland cancer	0.00128	0.00238	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MAP2K2—salivary gland cancer	0.00128	0.00238	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.00127	0.00237	CbGpPWpGaD
Boceprevir—ABCB1—lymph node—salivary gland cancer	0.00127	0.00275	CbGeAlD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.00127	0.00236	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FOXO3—salivary gland cancer	0.00125	0.00232	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MC3R—salivary gland cancer	0.00124	0.00231	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGFR4—salivary gland cancer	0.00124	0.0023	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGF16—salivary gland cancer	0.00124	0.0023	CbGpPWpGaD
Boceprevir—CTSS—Immune System—DTX4—salivary gland cancer	0.00123	0.00229	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FBXW7—salivary gland cancer	0.00122	0.00227	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—CDH1—salivary gland cancer	0.00121	0.00224	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00119	0.00222	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NUP62—salivary gland cancer	0.00119	0.0022	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CYLD—salivary gland cancer	0.00111	0.00207	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGFR4—salivary gland cancer	0.0011	0.00205	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGFR4—salivary gland cancer	0.0011	0.00205	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—DTX4—salivary gland cancer	0.00108	0.00202	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FBXW7—salivary gland cancer	0.00108	0.00201	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FBXW7—salivary gland cancer	0.00108	0.00201	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FOXO3—salivary gland cancer	0.00107	0.00199	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PRKDC—salivary gland cancer	0.00107	0.00198	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MAP2K2—salivary gland cancer	0.00106	0.00197	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FOXO3—salivary gland cancer	0.00103	0.00191	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGF16—salivary gland cancer	0.00102	0.00189	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NUP62—salivary gland cancer	0.000976	0.00181	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CREBBP—salivary gland cancer	0.000952	0.00177	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CREBBP—salivary gland cancer	0.000952	0.00177	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FOXO3—salivary gland cancer	0.000914	0.0017	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FOXO3—salivary gland cancer	0.000914	0.0017	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGFR4—salivary gland cancer	0.000913	0.0017	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CDH1—salivary gland cancer	0.000908	0.00169	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CDH1—salivary gland cancer	0.000908	0.00169	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FBXW7—salivary gland cancer	0.000898	0.00167	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF16—salivary gland cancer	0.000897	0.00167	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAP2K2—salivary gland cancer	0.000875	0.00163	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CREBBP—salivary gland cancer	0.000789	0.00147	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAML2—salivary gland cancer	0.000779	0.00145	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FOXO3—salivary gland cancer	0.000758	0.00141	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CDH1—salivary gland cancer	0.000752	0.0014	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGFR4—salivary gland cancer	0.000752	0.0014	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAP2K2—salivary gland cancer	0.000747	0.00139	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAP2K2—salivary gland cancer	0.000747	0.00139	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FBXW7—salivary gland cancer	0.00074	0.00137	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000729	0.00136	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PTEN—salivary gland cancer	0.00068	0.00126	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PTEN—salivary gland cancer	0.00068	0.00126	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—JAG1—salivary gland cancer	0.000665	0.00124	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGFR4—salivary gland cancer	0.000662	0.00123	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PTEN—salivary gland cancer	0.000653	0.00121	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PTEN—salivary gland cancer	0.000653	0.00121	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FBXW7—salivary gland cancer	0.000652	0.00121	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CREBBP—salivary gland cancer	0.00065	0.00121	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EP300—salivary gland cancer	0.000649	0.00121	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EP300—salivary gland cancer	0.000649	0.00121	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FOXO3—salivary gland cancer	0.000624	0.00116	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CDH1—salivary gland cancer	0.000619	0.00115	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAP2K2—salivary gland cancer	0.000619	0.00115	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.000607	0.00113	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PTEN—salivary gland cancer	0.000564	0.00105	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CREBBP—salivary gland cancer	0.000555	0.00103	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CREBBP—salivary gland cancer	0.000555	0.00103	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.000554	0.00103	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CDH1—salivary gland cancer	0.000551	0.00102	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDH1—salivary gland cancer	0.000551	0.00102	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FOXO3—salivary gland cancer	0.00055	0.00102	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PTEN—salivary gland cancer	0.000541	0.00101	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EP300—salivary gland cancer	0.000537	0.000999	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAP2K2—salivary gland cancer	0.000509	0.000947	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PIK3CA—salivary gland cancer	0.00048	0.000892	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PIK3CA—salivary gland cancer	0.00048	0.000892	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PTEN—salivary gland cancer	0.000464	0.000863	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000461	0.000856	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000461	0.000856	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CREBBP—salivary gland cancer	0.00046	0.000854	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CDH1—salivary gland cancer	0.000456	0.000848	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000449	0.000834	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PTEN—salivary gland cancer	0.000446	0.000828	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—salivary gland cancer	0.000444	0.000825	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HRAS—salivary gland cancer	0.000444	0.000825	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000443	0.000824	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EP300—salivary gland cancer	0.000443	0.000823	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HRAS—salivary gland cancer	0.000426	0.000792	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—salivary gland cancer	0.000426	0.000792	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.000413	0.000768	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PIK3CA—salivary gland cancer	0.000398	0.000739	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTEN—salivary gland cancer	0.000396	0.000736	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTEN—salivary gland cancer	0.000396	0.000736	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ISYNA1—salivary gland cancer	0.000385	0.000716	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000382	0.00071	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CREBBP—salivary gland cancer	0.000378	0.000703	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EP300—salivary gland cancer	0.000378	0.000702	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EP300—salivary gland cancer	0.000378	0.000702	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDH1—salivary gland cancer	0.000376	0.000698	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HRAS—salivary gland cancer	0.000368	0.000684	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000368	0.000683	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—salivary gland cancer	0.000353	0.000656	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000335	0.000623	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CREBBP—salivary gland cancer	0.000333	0.00062	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PTEN—salivary gland cancer	0.000328	0.00061	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PIK3CA—salivary gland cancer	0.000327	0.000609	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000314	0.000584	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MARCKS—salivary gland cancer	0.000314	0.000583	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EP300—salivary gland cancer	0.000313	0.000582	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—salivary gland cancer	0.000303	0.000563	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000298	0.000555	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PYGB—salivary gland cancer	0.000292	0.000542	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—salivary gland cancer	0.000291	0.000541	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.00029	0.00054	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CA—salivary gland cancer	0.000279	0.000519	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CA—salivary gland cancer	0.000279	0.000519	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—salivary gland cancer	0.00027	0.000502	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000266	0.000494	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000259	0.000482	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—salivary gland cancer	0.000259	0.000481	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—salivary gland cancer	0.000259	0.000481	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EP300—salivary gland cancer	0.000258	0.000479	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—salivary gland cancer	0.000247	0.000459	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—salivary gland cancer	0.000238	0.000443	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PHGDH—salivary gland cancer	0.000238	0.000442	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000237	0.00044	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CA—salivary gland cancer	0.000232	0.00043	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ST3GAL4—salivary gland cancer	0.000229	0.000426	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EP300—salivary gland cancer	0.000227	0.000422	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PYGB—salivary gland cancer	0.00022	0.000409	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—salivary gland cancer	0.000214	0.000398	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AQP1—salivary gland cancer	0.000208	0.000386	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000192	0.000357	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—salivary gland cancer	0.000191	0.000354	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000185	0.000344	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000179	0.000334	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000179	0.000333	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000177	0.000328	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—salivary gland cancer	0.000176	0.000328	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000173	0.000321	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—salivary gland cancer	0.000168	0.000312	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NUP62—salivary gland cancer	0.000165	0.000306	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—VCAN—salivary gland cancer	0.000164	0.000304	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—salivary gland cancer	0.000162	0.000302	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000157	0.000292	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—salivary gland cancer	0.000155	0.000289	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000146	0.000271	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000136	0.000252	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000131	0.000243	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000126	0.000235	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000124	0.000231	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000123	0.000229	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000111	0.000206	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000106	0.000198	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000103	0.000191	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AQP1—salivary gland cancer	9.66e-05	0.00018	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NUP62—salivary gland cancer	7.66e-05	0.000142	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—VCAN—salivary gland cancer	7.6e-05	0.000141	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CREBBP—salivary gland cancer	6.39e-05	0.000119	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CREBBP—salivary gland cancer	4.82e-05	8.97e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—salivary gland cancer	4.56e-05	8.49e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—EP300—salivary gland cancer	4.35e-05	8.09e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—salivary gland cancer	3.44e-05	6.4e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—EP300—salivary gland cancer	3.29e-05	6.11e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	3.22e-05	5.99e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CREBBP—salivary gland cancer	2.97e-05	5.52e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—salivary gland cancer	2.43e-05	4.52e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.12e-05	3.94e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—EP300—salivary gland cancer	2.02e-05	3.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.5e-05	2.78e-05	CbGpPWpGaD
